Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 403
Selected: 0
NCT IDTitle
NCT03148327Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy
NCT03596710Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy
NCT07323641Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
NCT00052273LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
NCT00719030A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
NCT02425228Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer
NCT06387173Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
NCT06075589Psychoeducation for Uveal Melanoma
NCT00003225Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00088946Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
NCT00021268Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer
NCT04457232Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation
NCT03996850SPECT/CT for the Characterization of Renal Masses
NCT0010099717-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate
NCT00047255Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
NCT00798876Low-Fat Fish Oil Diet for Prostate Cancer Prevention
NCT00040989BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
NCT00098917Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
NCT06064682An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
NCT05496959177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
NCT00004979Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors
NCT00509431Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
NCT00060086Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
NCT05523700Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)
NCT00612001Vaccine Therapy in Treating Patients With Malignant Glioma
NCT03672773Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer
NCT02826395C11 Sodium Acetate PET/CT Imaging of PCa
NCT01783756Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis
NCT05688215Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
NCT06543576External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
NCT01536743A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression
NCT00471887Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma
NCT00444223Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants
NCT06047509Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance
NCT01558258A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors
NCT00079222Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT00005083Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00112983Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT01697527Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
NCT00098462Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00004050Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
NCT04299620Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy
NCT00005082Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
NCT01144247Cellular Immunotherapy Study for Brain Cancer
NCT00021008ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer
NCT03541850Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
NCT07716735Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer
NCT07191717Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
NCT00071968Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
NCT00012116Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain